Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 ... Aadi Bioscience Inc.January 11, 2021 GMT Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China EOC Pharma acquires exclusive development and commercialization rights to ABI-009 in Greater China Aadi will receive an upfront payment, regulatory and sales milestone payments totaling up to $271M plus royalties PACIFIC PALISADES, CALIFORNIA and SHANGHAI...
Source: apnews.com